Ingrid Murillo Jelsbak is since January 2016 the Clinical Research Director at Biofabri, which belongs to Zendal Group at Porriño, a Spanish biopharmaceutical Business Group, focussed on the development manufacturing and marketing of vaccines as well as biological and pharmaceutical products for both human and animal health.
After finishing studies in Biology, with specialization in zoology at Universidad Complutense, Madrid, she started her carrier at Pharma Industry where she has been for the last 20 years exercising several responsibilities mainly in the Clinical Research area at Pharmaceutical companies and Contract Research Organizations (CROs) covering several responsibilities at national and international level, reaching the Managing Direction level for the Iberian region at Chiltern International, a UK-based international CRO, during six years.
Ingrid Murillo Jelsbak is since January 2016 the Clinical Research Director at Biofabri, which belongs to Zendal Group at Porriño, a Spanish biopharmaceutical Business Group, focussed on the development manufacturing and marketing of vaccines as well as biological and pharmaceutical products for both human and animal health.
After finishing studies in Biology, with specialization in zoology at Universidad Complutense, Madrid, she started her carrier at Pharma Industry where she has been for the last 20 years exercising several responsibilities mainly in the Clinical Research area at Pharmaceutical companies and Contract Research Organizations (CROs) covering several responsibilities at national and international level, reaching the Managing Direction level for the Iberian region at Chiltern International, a UK-based international CRO, during six years.